Growth Metrics

GeneDx Holdings (WGS) Other Non-Current Liabilities (2020 - 2025)

Historic Other Non-Current Liabilities for GeneDx Holdings (WGS) over the last 6 years, with Q3 2025 value amounting to $4.3 million.

  • GeneDx Holdings' Other Non-Current Liabilities fell 6855.24% to $4.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 million, marking a year-over-year decrease of 6855.24%. This contributed to the annual value of $5.5 million for FY2024, which is 6254.5% down from last year.
  • As of Q3 2025, GeneDx Holdings' Other Non-Current Liabilities stood at $4.3 million, which was down 6855.24% from $3.3 million recorded in Q2 2025.
  • Over the past 5 years, GeneDx Holdings' Other Non-Current Liabilities peaked at $61.4 million during Q3 2021, and registered a low of $3.3 million during Q2 2025.
  • Over the past 5 years, GeneDx Holdings' median Other Non-Current Liabilities value was $20.2 million (recorded in 2022), while the average stood at $18.1 million.
  • Examining YoY changes over the last 5 years, GeneDx Holdings' Other Non-Current Liabilities showed a top increase of 95626.81% in 2021 and a maximum decrease of 8550.78% in 2021.
  • GeneDx Holdings' Other Non-Current Liabilities (Quarter) stood at $21.9 million in 2021, then rose by 9.64% to $24.0 million in 2022, then tumbled by 38.65% to $14.7 million in 2023, then tumbled by 62.54% to $5.5 million in 2024, then fell by 22.85% to $4.3 million in 2025.
  • Its Other Non-Current Liabilities stands at $4.3 million for Q3 2025, versus $3.3 million for Q2 2025 and $6.6 million for Q1 2025.